According to a recent market study published by Growth Market Reports, titled, “Active Wound Care Market by Drug Type, by Application, and by Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 8,297.2 Million in 2022 and is expected to expand at a growth rate of 4.4% by 2031.

Active wound care refers to a set of interventions and treatments aimed at promoting wound healing and preventing infection. It involves the use of various techniques and products to create an optimal environment for the healing process. The role of active wound care products is to promote wound healing and prevent complications through proactive interventions.

Get Sample Report @

The Active Wound Care market has been fragmented based on type, and application. By type, the global Active Wound Care market is categorized as dressings, and Grafts & Skin Substitutes. By application, the market is segmented as surgical wounds, ulcers, and others. Considering regions, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

The Coronavirus disease 2019 (COVID-19) pandemic highlighted economic disparities, global interdependence, and governance challenges. However, the COVID-19 outbreak has slightly negative impact on Active Wound Care, due to the lack of a defined line of supply chain during the pandemic. Supply chain issues led to challenges in the production and distribution of active wound care products, causing delays in delivery and shortages in some regions.

As per Growth Market Reports industry analyst, Ruchika Sharma, “The expanding healthcare and rising diabetic patients are expected to contribute to the growth of the global Active Wound Care market. Increasing investments from key market players for R&D activities and a rising focus on product innovations are expected to trigger the demand for Active Wound Care in the coming years. Demand for Active Wound Care is projected to grow in the coming years, due to the rising number of patients suffering from diabetic foot ulcers and surgical wounds.

A supply chain is a network between manufacturers and suppliers to produce and distribute a specific product to the final buyers. This network includes different people, regulatory bodies, entities, information, and resources. Entities in the supply chain include raw material suppliers, manufacturers, logistics, warehouses, pharmacies, finance, distributors, and customers. Supply chain management is an essential part of any business. If the supply chain of Active Wound Care is hampered, the patients suffering from chronic ailments of post-surgical wounds are not treated on time, resulting in severe diseases.

Key Takeaways from the Study

  • Players in the global Active Wound Care market include Smith+Nephew, Mölnlycke Health Care AB, Cardinal Health, Convatec Group PLC, Organogenesis Inc., Medline Industries, LP, Integra LifeSciences, Coloplast, MIMEDX Group, Inc., and 3M held a major market share of the Active Wound Care market in 2022.

  • The rising incidence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, drives the active wound care market.

  • In terms of type, the global Active Wound Care market is categorized as dressings Grafts & Skin Substitutes. The Grafts & Skin Substitutes segment is projected to expand at a significant CAGR during the forecast period, as it helps with autolytic debridement and provides pain relief.

  • In terms of regions, the global Active Wound Care market is divided into North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. North America is projected to account for a significant share of the Active Wound Care market during the forecast period, owing to the increasing facilities for treatment and well-established healthcare system in the region. The market in the Asia Pacific is anticipated to grow at a rapid pace due to the rising patient base of diabetic ulcers and surgical wounds.

Report Scope:

Report Metric


Market Value in 2022

US$ 8,297.2 Million

Market Growth Rate (from 2022 to 2030)

4.4 %

Historical Data

2016 & 2021

Base Year


Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By type, By Application, and by region

Key Companies Profiled

Smith+Nephew, Mölnlycke Health Care AB, Cardinal Health, Convatec Group PLC, Organogenesis Inc., Medline Industries, LP, Integra LifeSciences, Coloplast, MIMEDX Group, Inc., and 3M.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet research requirements


Target Audience:

  • Supply-side: Manufacturers and distributors

  • Demand Side: Healthcare industry and pharmaceutical industry

  • Regulatory Side: Concerned government authorities and other approved regulatory bodies

  • Associations and Industry Bodies: Food and Drug Administration (FDA) and World Health Organization (WHO)